ID

12475

Description

The study is designed to compare the efficacy and safety profile of cangrelor to standard of care in patients require percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01156571

Lien

https://clinicaltrials.gov/ct2/show/NCT01156571

Mots-clés

Versions (1)
  1. 21/11/2015 21/11/2015 -
Téléchargé le

21 novembre 2015

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility CHAMPION PHOENIX Acute Coronary Syndrome NCT01156571

Anglais

Eligibility Criteria

1 Formulaires  
  1. StudyEvent: ODM
    1. Eligibility Criteria
Inclusion Criteria
Description

Inclusion Criteria

Male or non-pregnant female
Description

Male or non-pregnant female

Type de données

boolean

Alias
UMLS CUI-1
C0079399
non-pregnant female
Description

non-pregnant female

Type de données

boolean

Alias
UMLS CUI-1
C0549206
at least 18 years of age
Description

at least 18 years of age

Type de données

boolean

Alias
UMLS CUI-1
C0001779
Patients undergoing percutaneous coronary intervention (PCI)
Description

Patients undergoing percutaneous coronary intervention (PCI)

Type de données

boolean

Alias
UMLS CUI-1
C1532338
Stable angina (SA) patients
Description

Stable angina (SA) patients

Type de données

boolean

Alias
UMLS CUI-1
C0002962
with diagnostic coronary angiography
Description

with diagnostic coronary angiography

Type de données

boolean

Alias
UMLS CUI-1
C0085532
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
Description

Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis

Type de données

boolean

Alias
UMLS CUI-1
C3537184
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
Description

Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis

Type de données

boolean

Alias
UMLS CUI-1
C0948089
ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
Description

ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)

Type de données

boolean

Alias
UMLS CUI-1
C1536220
Provide written informed consent
Description

Provide written informed consent

Type de données

boolean

Alias
UMLS CUI-1
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
Description

Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization

Type de données

boolean

Alias
UMLS CUI-1
C2936588
Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
Description

Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)

Type de données

boolean

Alias
UMLS CUI-1
C0253563
Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
Description

Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)

Type de données

boolean

Alias
UMLS CUI-1
C0247025
Abciximab usage within 7 days preceding randomization
Description

Abciximab usage within 7 days preceding randomization

Type de données

boolean

Alias
UMLS CUI-1
C0288672
Receipt of fibrinolytic therapy in the 12 hours preceding randomization
Description

Receipt of fibrinolytic therapy in the 12 hours preceding randomization

Type de données

boolean

Alias
UMLS CUI-1
C0040044
Increased bleeding risk
Description

Increased bleeding risk

Type de données

boolean

Alias
UMLS CUI-1
C3251812
ischemic stroke within the last year or any previous hemorrhagic stroke
Description

ischemic stroke within the last year or any previous hemorrhagic stroke

Type de données

boolean

Alias
UMLS CUI-1
C0038454
tumor
Description

tumor

Type de données

boolean

Alias
UMLS CUI-1
C0006826
cerebral arteriovenous malformation
Description

cerebral arteriovenous malformation

Type de données

boolean

Alias
UMLS CUI-1
C0003857
intracranial aneurysm
Description

intracranial aneurysm

Type de données

boolean

Alias
UMLS CUI-1
C0007766
recent (<1 month) trauma
Description

recent (<1 month) trauma

Type de données

boolean

Alias
UMLS CUI-1
C3263723
major surgery (including bypass surgery)
Description

major surgery (including bypass surgery)

Type de données

boolean

Alias
UMLS CUI-1
C0679637
currently receiving warfarin
Description

currently receiving warfarin

Type de données

boolean

Alias
UMLS CUI-1
C0043031
active bleeding
Description

active bleeding

Type de données

boolean

Alias
UMLS CUI-1
C0019080
Retour au début de la page

Similar models

Eligibility Criteria

1 Formulaires
  1. StudyEvent: ODM
    1. Eligibility Criteria
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion Criteria
Gender
Item
Male or non-pregnant female
boolean
C0079399 (UMLS CUI-1)
Pregnancy
Item
non-pregnant female
boolean
C0549206 (UMLS CUI-1)
Age
Item
at least 18 years of age
boolean
C0001779 (UMLS CUI-1)
PCI
Item
Patients undergoing percutaneous coronary intervention (PCI)
boolean
C1532338 (UMLS CUI-1)
Angina pectoris
Item
Stable angina (SA) patients
boolean
C0002962 (UMLS CUI-1)
Coronary angiography
Item
with diagnostic coronary angiography
boolean
C0085532 (UMLS CUI-1)
NSTEMI
Item
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
boolean
C3537184 (UMLS CUI-1)
Acute coronary syndrome
Item
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
boolean
C0948089 (UMLS CUI-1)
STEMI
Item
ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
boolean
C1536220 (UMLS CUI-1)
Informed consent
Item
Provide written informed consent
boolean
C0021430 (UMLS CUI-1)
Item Group
Exclusion Criteria
Thienopyridines
Item
Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
boolean
C2936588 (UMLS CUI-1)
Eptifibatide
Item
Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
boolean
C0253563 (UMLS CUI-1)
Tirofiban
Item
Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
boolean
C0247025 (UMLS CUI-1)
Abciximab
Item
Abciximab usage within 7 days preceding randomization
boolean
C0288672 (UMLS CUI-1)
Thrombolytic Therapy
Item
Receipt of fibrinolytic therapy in the 12 hours preceding randomization
boolean
C0040044 (UMLS CUI-1)
Bleeding risk
Item
Increased bleeding risk
boolean
C3251812 (UMLS CUI-1)
Stroke
Item
ischemic stroke within the last year or any previous hemorrhagic stroke
boolean
C0038454 (UMLS CUI-1)
Tumor
Item
tumor
boolean
C0006826 (UMLS CUI-1)
Cerebral arteriovenous malformation
Item
cerebral arteriovenous malformation
boolean
C0003857 (UMLS CUI-1)
intracranial aneurysm
Item
intracranial aneurysm
boolean
C0007766 (UMLS CUI-1)
Trauma
Item
recent (<1 month) trauma
boolean
C3263723 (UMLS CUI-1)
Major surgery
Item
major surgery (including bypass surgery)
boolean
C0679637 (UMLS CUI-1)
Warfarin
Item
currently receiving warfarin
boolean
C0043031 (UMLS CUI-1)
Hemorrhage
Item
active bleeding
boolean
C0019080 (UMLS CUI-1)
Retour au début de la page 

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial